Search results for: 'biological solutions'

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) ) profiles a wide range of innovations from the advanced medical devices, digital health, and diagnostics industry. The issue includes advanced medical devices such as sub-cutaneous implant for lymphedema therapy, portable cooling device, high-definition blood vessels imaging ...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

05 Aug 2021  |  Global  |  Market Research

Global Wound Care Solutions and New-age Technology Growth Opportunities

Growth Strategies Driven by Increasingly Advanced and Digital Solutions

Infographics

×

The entire healthcare industry is undergoing a transformation in the wake of the COVID-19 pandemic, and the global wound care industry is no exception. As concerns about aged patients contracting COVID-19 increased, care delivery began a gradual shift toward a home setting. As a result, participants in the wound care industry are investing heavily ...

03 Jun 2025  |  Global  |  Market Research

Advanced Visualization Solutions for Medical Imaging, Global, 2024–2029

Advanced Visualization Solutions for Cardiovascular and Neurology Conditions are Driving Transformational Growth

Infographics

×

The medical imaging industry is undergoing significant changes as it grapples with escalating challenges, including the surge in imaging exams, which leads to increasing workloads for radiologists; complex diagnostic tasks; and a global shortage of trained staff, placing a growing burden on both radiologists and healthcare systems.In response, tech...

Dental practices and dental laboratories in Spain have recognized the importance of adopting digital dental solutions. Digital dental solutions continue to record substantial growth, and are these expected to continue expansion as business models and significant value offerings continue to evolve in tandem with the fast-paced world of connected hea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

Healthcare systems today are facing a convergence of pressures that threaten both operational stability and patient outcomes. Workforce shortages, clinician burnout, rising costs, and persistent health inequities are compounded by the growing demands of an aging population with complex needs.These challenges are not isolated—they interact and inten...